On Friday, Shares of Morgan Stanley (NYSE:MS), lost -0.19% to $31.43.
Morgan Stanley, will declare its third quarter 2015 financial results on Monday, October 19, 2015, at about 7 a.m. (ET). A conference call to discuss the results will be held on Monday, October 19, 2015, at 8:30 a.m. (ET).
Morgan Stanley is a financial holding company. Through its subsidiaries and affiliates, the Company provides a variety of products and financial services to a group of clients and customers, including corporations, governments, financial institutions and individuals.
Shares of Yamana Gold Inc. (USA) (NYSE:AUY), inclined 11.59% to $1.83, during its last trading session.
Yamana Gold, will release its third quarter 2015 results after market close on October 29, 2015 followed by a conference call and webcast on October 30, 2015 at 9:00 a.m. ET.
Yamana Gold Inc. is a Canada-based gold producer. The Company is engaged in gold mining and related activities, including exploration, extraction, processing and reclamation. The Company’s production mines include Chapada, Brazil; El Penon, Chile; Canadian Malartic, Canada; Mercedes, Mexico; Gualcamayo, Argentina; Jacobina, Brazil; Minera Florida, Chile, and Other Producing Mines.
Shares of ENSCO PLC (NYSE:ESV), inclined 7.58% to $14.56, during its last trading session, as oil prices ticked higher due to a lower number of oil rigs in operation in the U.S.
Prices of the commodity were higher after Baker Hughes (BHI) said the number of active oil rigs in the U.S. fell by 26 to 614 rigs in the week. The lower rig count is a sign that U.S. oil output may see a more noteworthy decrease soon, according to the Wall Street Journal.
Ensco plc (Ensco) is a global offshore contract drilling company. The Company provides offshore contract drilling services to the international oil and gas industry. The Company operates in three segments: Floaters, which includes its drill ships and semisubmersible rigs; Jackups and Other, which consists of management services on rigs owned by third-parties.
Finally, Johnson & Johnson (NYSE:JNJ), ended its last trade with 0.79% gain, and closed at $93.92.
Johnson & Johnson, declared the completion of the divestiture of its Cordis business to Cardinal Health for an approximate value of $2 billion, subject to customary adjustments.
The Cordis business is a global leader in the development and manufacture of interventional vascular technology and generated net revenues of about $780 million in 2014.
Johnson & Johnson remains dedicated to combating cardiovascular disease through its electrophysiology business, Biosense Webster, in the Medical Devices segment, and its leading cardiovascular medicine, XARELTO®, in the Pharmaceutical segment.
Johnson & Johnson is a holding company. The Company is engaged in the research and development, manufacture and sale of a range of products in the health care field. The Company has more than 265 operating companies conducting business around the world.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
